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Abstract
Pathogen strains may diﬀer in virulence because they attain diﬀerent loads in their hosts, or because
they induce diﬀerent disease-causing mechanisms independent of their load. In evolutionary ecology, the
latter is referred to as ”per-parasite pathogenicity”. Using viral load and CD4+ T cell measures from
2014 HIV-1 subtype B infected individuals enrolled in the Swiss HIV Cohort Study, we investigated
if virulence — measured as the rate of decline of CD4+ T cells — and per-parasite pathogenicity are
heritable from donor to recipient. We estimated heritability by donor-recipient regressions applied to 196
previously identified transmission pairs, and by phylogenetic mixed models applied to a phylogenetic tree
inferred from HIV pol sequences. Regressing the CD4+ T cell declines and per-parasite pathogenicities
of the transmission pairs did not yield heritability estimates significantly diﬀerent from zero. With the
phylogenetic mixed model, however, our best estimate for the heritability of the CD4+ T cell decline
is 17% (5%–30%), and that of the per-parasite pathogenicity is 17% (4%–29%). Further, we confirm
that the set-point viral load is heritable, and estimate a heritability of 29% (12%–46%). Interestingly,
the pattern of evolution of all these traits diﬀers significantly from neutrality, and is most consistent
with stabilizing selection for the set-point viral load, and with directional selection for the CD4+ T cell
decline and the per-parasite pathogenicity. Our analysis shows that the viral genetype aﬀects virulence
mainly by modulating the per-parasite pathogenicity, while the indirect eﬀect via the set-point viral load
is minor.
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Introduction
The virulence of an infection is determined by
both, the host and the pathogen. One of the most
common modulators of virulence is the pathogen
load. Higher load often leads to more morbidity,
or to faster disease progression or death. Similar
to virulence, the load that a pathogen strain
attains is also determined by both, the host
and the pathogen. In evolutionary ecology, hosts
that limit virulence by reducing pathogen load
are called “resistant”, and pathogen strains that
attain a high load in their hosts are often termed
“virulent”.
But virulence is not completely determined by
the pathogen’s load alone. There are pathogen-
load-independent components, which are again
influenced by the host and the pathogen. A host
that suﬀers less than average from being infected
by a pathogen and carrying a specific load is called
“tolerant” (Ayres and Schneider, 2012; Boots,
2008; Boots et al., 2009; Caldwell et al., 1958;
Little et al., 2010; Medzhitov et al., 2012; R˚aberg,
2014; R˚aberg et al., 2007, 2009; Read et al.,
2008; Schafer, 1971; Schneider and Ayres, 2008).
A pathogen strain that causes less than average
virulence attaining a specific load is said to have
a low “per-parasite pathogenicity” (R˚aberg, 2014;
R˚aberg and Stjernman, 2012). Fig 1A displays
these virulence components diagrammatically.
How can pathogen-load-independent
components of virulence be determined? To
identify these components, “excess virulence”
needs to be measured, i. e. by how much virulence
diﬀers from what is expected for a specific
pathogen load. Statistically speaking, “excess
virulence” is the residual virulence after adjusting
for diﬀerences in pathogen load. This adjustment
can be visualized on fitness-versus-pathogen-load
plots (Fig 1B). On such a plot, host types
with diﬀering levels of disease tolerance are
characterized by diﬀerent tolerance curves that
depict the relationship between virulence and
pathogen load (see Fig 1B bottom left). The
steepness of this curve is inversely related to
disease tolerance.
Once tolerance curves for diﬀerent host types
are determined, the per-parasite pathogenicity
will manifest itself as a yet unexplained deviation
from the tolerance curve. In other words, varying
degrees of per-parasite pathogenicity will lead to
residual excess virulence that is not explained by
host factors. Fig 1C shows how two pathogen
strains diﬀering in their per-parasite pathogenicity
will scatter around the tolerance curves of two
host types.
HIV infection provides an ideal example to
illustrate this decomposition of virulence. In this
infection, CD4+ T cells — the target cells of
the virus — continuously decline from a level of
approximately 1000 cells per microliter blood. A
CD4+ T cell count below 200 cells per microliterc⃝ The Author 2013. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution. All rights reserved.
For permissions, please email: journals.permissions@oup.com
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FIG. 1. Dissecting virulence. (A) Systematics of virulence components. Each component can be a trait of either the
pathogen or the host, and depend or be indepependent of the load of the pathogen. (B) Formally, virulence can be dissected
using fitness-versus-pathogen-load plots. (In these plots, host fitness is inversely correlated with virulence.) Adapted from
Figure 1 in Raberg (R˚aberg, 2014). (C) In multi-host multi-pathogen systems, virulence components can be disentangled
by first defining host-type-specific tolerance curves. Pathogens diﬀering in their per-parasite pathogenicity will then fall on
diﬀerent sides of these tolerance curves. In the example shown, pathogen B has a higher per-parasite pathogenicity than
pathogen A.
blood is one of the defining characteristics of
AIDS. The decline rate of the CD4+ T cells
is a well-established surrogate for the rate of
disease progression (Phillips et al., 1991), i.e.
virulence. It has the advantage that it can be
determined from clinical samples spanning less
than one year of monitoring an HIV infected
individual, while the direct observation of disease
progression requires many years. The existence of
such a well-established, quantitative measure of
virulence makes HIV infection unique.
The decomposition of virulence relies on
its relation with pathogen load. During HIV
infection, the viral load rises and peaks a few
weeks after infection, and subsequently settles at
a fairly stable level that is maintained for many
years — the so-called set-point viral load. This
set-point viral load represents a good measure
of pathogen load required for the decomposition
3
Bertels et al. · doi:10.1093/molbev/mst MBE
of virulence, and it is associated with the rate
of progression toward disease and death (Mellors
et al., 1996). However, the correlation between
the set-point viral load and the decline of the
CD4+ T cells — a good proxy of the rate of
disease progression — is not very strong: R2
values were found to be between 0.05–0.08 in
American cohorts (Rodriguez et al., 2006), and
0.05 for the population studied here (Regoes
et al., 2014) (although the relationship between
set-point viral load and survival time has been
reported to be higher (Arnaout et al., 1999).)
While this weak correlation may be in part the
result of measurement error it suggests that there
are factors influencing virulence other than the
set-point viral load.
In the context of HIV infection, examples for
variation in all of the four virulence components
exist. First, the set-point viral load diﬀers by
three orders of magnitude between HIV infected
individuals, ranging from 103 to 106 RNA copies
per ml plasma (Deeks et al., 1997; Mellors et al.,
1996; Raboud et al., 1996). This variation is
associated with the rate of disease progression
(Mellors et al., 1996), i.e. virulence. Recent
heritability studies (as reviewed in Fraser et al.
(2014)) have shown that a fraction of the variation
in the set-point viral load can be attributed to the
viral genotype infecting the host.
Second, human genes conferring “host
resistance” in the sense of evolutionary ecology
(see above) have been identified: Individuals
who carry protective HLA-B alleles have lower
set-point viral loads, and progress to disease at
a slower rate than people without these alleles
(Fellay et al., 2007; Goulder and Watkins, 2008).
Across primates, species-specific restriction
factors can limit the load of Human and Simian
Immunodeficiency Viruses (Kirchhoﬀ, 2009;
Zheng et al., 2012).
Third, in the context of immunodeficiency
viruses, examples for variation in pathogen-load-
independent virulence components exist. Simian
Immunodeficiency Virus (SIV) infection in natural
hosts, such as the sooty mangabeys, is avirulent
despite the high set-point viral loads SIV
attains in these hosts (Chahroudi et al., 2012;
Chakrabarti, 2004). In contrast, SIV infection in
non-natural hosts, such as the rhesus macaque,
leads to an AIDS-like disease (Chahroudi et al.,
2012; Chakrabarti, 2004). Thus, natural hosts
tolerate the infection without becoming sick.
There is also variation in tolerance to HIV
infection in humans associated with age and
human leukocyte antigens (HLA) (Regoes et al.,
2014).
Lastly, there is also variation in per-parasite
pathogenicity across viral strains. For example,
there is evidence that HIV-1 subtype D leads to
faster disease progression than subtype A even
though both subtypes attain similar set-point
viral loads (Baeten et al., 2007). In other words,
subtype A and D diﬀer in their per-parasite
pathogenicity.
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Previously, we investigated if humans display
variation in disease tolerance against HIV (Regoes
et al., 2014). We found that younger individuals
and HLA-B heterozygotes are more tolerant, and
could link the variation in tolerance to HLA-B
genotype. In this previous study, we did, however,
not investigate the potential impact of the virus
genotype on virulence.
How can one investigate if the virus genotype
influences a host-pathogen trait? One way
is to study associations between genetic
polymorphisms of the virus and the trait, as
is done, for example, in genome-wide association
studies (Bartha et al., 2013). An alternative
approach is to estimate the heritability of the
trait. If a trait is heritable, i. e. similar between
similar viral genotypes, it must, at least in part,
be determined by viral genes.
The influence of the virus genotype on the
set-point viral load has been the focus of many
research groups, including ours, over the past
years. Most studies determined the heritability
of the set-point viral load (Alizon et al., 2010;
Fraser et al., 2014; Hodcroft et al., 2014;
Hollingsworth et al., 2010; Mu¨ller et al., 2011),
while others investigated associations between
genetic polymorphisms of the virus and the trait
(Bartha et al., 2013). There is a consensus that
set-point viral load is heritable, although there is
some controversy on the numerical value of the
heritability.
In this study, we investigate the influence of the
HIV genotype on overall virulence, as measured by
the CD4+ T cell decline, and its pathogen-load-
dependent and -independent components, the set-
point viral load and per-parasite pathogenicity,
respectively. We determine the influence of the
viral genotype by estimating the “heritability” of
these traits, i. e. the correlation of each of these
traits in donor and recipient. To this end, we
use data from the Swiss HIV Cohort Study. For
our analysis, we selected cohort participants, for
whom we could determine the set-point viral load
and the decline of CD4+ T lymphocytes — an
established proxy for virulence in HIV infection.
As a surrogate for the per-parasite pathogenicity
we use the residuals from previously determined
tolerance curves (Regoes et al., 2014) as described
in Methods and Materials.
Our analysis confirms that set-point viral load
is heritable. We further provide evidence that the
decline of CD4+ T lymphocytes, i. e. virulence,
is heritable. Lastly, we find evidence for the
heritability of the per-parasite pathogenicity,
the pathogen-load-independent component of
virulence. Our results are therefore consistent
with the notion that the virus genotype aﬀects
virulence in HIV infection both via the viral load,
and via viral-load-independent mechanisms.
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Methods and Materials
Study population
We analysed a subset of the individuals from the
Swiss HIV Cohort Study (www.shcs.ch) (Schoeni-
Aﬀolter et al., 2010). This study has enrolled more
than 19’000 HIV-infected individuals to date,
which constitutes more than 72% of all patients
receiving antiretroviral therapy in Switzerland,
and is therefore highly representative. The viral
load and CD4+ T cell count of each enrolled
individual are determined approximately every
three months. In some of these individuals, the
pol gene of the virus was sequenced. The pol
gene encodes viral enzymes important for viral
replication within its target cell, most notably
the reverse transcriptase, the integrase, and the
protease, and contains many of the clinically
relevant resistance mutations.
The study population of the present study
consists of a subset of the study population
analyzed in a previous study (Regoes et al.,
2014). In this previous study, we had included
3036 HIV-1 infected individuals, for whom viral
load measurements and CD4+ T cell counts were
available to reliably estimate the set-point viral
load and CD4+ T cell decline. We restricted our
analysis to data obtained before antiretroviral
treatment. Furthermore, we excluded the primary
and late phases of the infection by discarding
measurements during the first 90 days after the
estimated date of infection and measurements
obtained when the CD4+ T cell count was
below 100 per microliter blood. Lastly, individuals
were included if they had at least two viral
load measurements and three CD4+ T cell
measurements that were at least 180 days apart.
For the present study, we selected 2014
individuals of the 3036 individuals enrolled
previously. Individuals were included if the pol
gene of their virus had been sequenced. The
genetic information of the virus was necessary for
the present study to infer the evolutionary history
and investigate patterns of heritability.
Pol sequence information was obtained
from the SHCS genotypic drug resistance
database. Sequences are stored in a central
database (SmartGene; Integrated Database
Network System version 3.6.13). All laboratories
perform population-based sequencing (von Wyl
et al., 2007; Yang et al., 2015). The drug
resistance database includes, in addition to
the routinely collected samples, over 11’000
samples from the biobank analyzed by systematic
retrospective sequencing (Schoeni-Aﬀolter et al.,
2010; Yang et al., 2015). The individuals in our
study population belong to the following risk
groups: men having sex with men – 972 (48%),
heterosexuals – 435 (21.5%), intravenous drug
users – 365 (18%), and others – 252 (12.5%).
The SHCS, enrolling HIV-infected adults aged
over 16 years old, has been approved by ethics
committees of all participating institutions.
The data collection was anonymous and
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written informed consent was obtained from
all participants (Schoeni-Aﬀolter et al., 2010).
Set-point viral loads and CD4+ T cell
declines
For each individual enrolled in our study, the set-
point viral load had been determined in a previous
study (Regoes et al., 2014) as the mean of the
logarithm to the base 10 of the eligible viral load
measurements in each individual. Non-detectable
viral loads had been set to half the detection limit.
The rate at which the CD4+ T cells change per
day had previously been estimated as the slope in
a linear regression of CD4+ T cell counts in an
individual against the date, at which they were
determined. The rate of change in CD4+ T cells
is inversely related to virulence.
Set-point viral loads and CD4+ T cell
declines were adjusted for potential covariates by
regressing them against sex, age at infection, risk
group and ethnicity. Once significant covariates
were identified, adjusted traits were defined as
the residuals of a regression with these covariates.
Subsequent analyses were then conducted with the
residuals.
The inclusion criteria, calculation of set-point
viral load and CD4+ T cell decline, as well
as the model fitting and comparisons had been
implemented and performed in the R language of
statistical computing (R Core Team, 2013).
Per-parasite pathogenicity
Per-parasite pathogenicity is defined as the
pathogenic potential of a pathogen strain
FIG. 2. As a surrogate for the per-parasite
pathogenicity we use the residuals from age-
adjusted tolerance curves. In the graph, we plotted
each individual’s CD4+ T cell decline versus his/her set-
point viral load. The red and blue curves show the average
relationships between these two measures in the groups
that were 20 and 60 years old at the time of their
infection, respectively. These age-adjusted tolerance curves
were determined previously (Regoes et al., 2014). The red
square and blue triangle highlight two individuals with an
age at infection of 20 and 60 years, respectively.
adjusted for its load and host factors that
are associated with pathogen-load independent
virulence components, i.e. tolerance.
To derive a proxy for the per-parasite
pathogenicity of a strain, we first determined
the relationship between pathogen load and
pathogenicity — called the tolerance curve — for
a given host type. In our previous study (Regoes
et al., 2014), we found that the age, at which the
host was infected, was associated very strongly
with the slope of the tolerance curve. Therefore,
we determined the tolerance curve specific for the
age of the host that harbors the pathogen strain.
We did not account for host factors other than
age, such as, for example, HLA-B genotype or
homozygosity, because this information of host
genotype is lacking for the majority of our study
population.
In a next step, we predicted the CD4+ T cell
decline we should observe given the set-point viral
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load that this strain attains in the host. Lastly, we
calculated by how much the observed CD4+ T cell
decline deviates from this prediction (see Fig 2).
In our conceptualization, tolerance is measured
by the parameter characterizing the relationship
between the CD4+ T cell decline and the set-
point viral load. Diﬀerent levels of per-parasite
pathogenicity, on the other hand, manifest
themselves as a deviation of an individual’s CD4+
T cell decline and set-point viral load from the
tolerance curve. Formally, this procedure amounts
to regressing CD4+ T cell decline against the set-
point viral load, adjusting for the age at infection,
and calculating the residual of an individual’s
trait from the regression line. We denote this
proxy as ppp. Lower and more negative values
of this quantity are associated with faster disease
progression.
Transmission pairs and phylogenetic tree
The transmission pairs were identified as
monophyletic clusters on a previous HIV
transmission tree (Kouyos et al., 2014). Of
these previously established transmission pairs,
196 were present in our study population. The
direction of transmission cannot be inferred in
these pairs.
The reconstruction of the phylogenetic tree
relies on pol gene sequencing of the virus
carried by the study subjects. In particular,
we had sequences of pol extending over the
HXB2 positions 2253–3870, comprising the
protease and the reverse transcriptase. All
sequences were initially aligned to an HXB2
reference genome (http://www.ncbi.nlm.nih.gov/
nuccore/K03455.1) using MUSCLE (Edgar,
2004). We selected the earliest sequence if more
than one sequence was available for a person.
To reconstruct the evolutionary history, we
first removed insertions relatively to HXB2.
To exclude signatures of parallel evolution due
to drug pressure that can distort the inferred
evolutionary history, we further removed drug
resistance mutations according to the databases
of Stanford (http://hivdb.stanford.edu/)
and the International Antiviral Society
(https://www.iasusa.org/). We used Gblocks
to refine the alignment. The final number of
positions was 1106.
We constructed the phylogenetic tree using
FastTree (Version 2.1.8 SSE3, OpenMP) (Price
et al., 2010). We used a maximum-likelihood-
based inference using a Generalized Time-
Reversible evolutionary model and a CAT
model (Stamatakis, 2006a) with 20 discrete
evolutionary rate categories. We use the most
rigorous and time-consuming FastTree parameters
(FastTreeMP -pseudo -spr 4 -mlacc 2 -slownni -
gtr -nt). We rooted the tree with 10 Subtype C
sequences as an outgroup, using the R package
APE. The branch lengths in our tree correspond
to genetic distances between the sequences, and
not to time.
We also compared the results obtained from
this tree with those of two trees reconstructed
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with RaxML (Stamatakis, 2006b). These trees
were reconstructed assuming a Generalized Time-
Reversible evolutionary model. One assumed
CAT model with 25 discrete evolutionary rate
categories, the other Γ-distributed evolutionary
rates. Table S1 shows that there is genrally good
agreement between the results.
Heritability estimation
To estimate the heritability of the three traits —
set-point viral load, CD4+ T cell decline and per-
parasite pathogenicity — we used two approaches.
First, we applied donor-recipient regressions
that are formally equivalent to parent-oﬀspring
regressions (Fraser et al., 2014) to the 196
previously identified transmission pairs. Although
we do not have any information on the direction
of transmission in these pairs, we expect that a
regression between the trait in question will yield a
good estimate of the heritability (Bachmann et al.,
2017).
Second, we employed phylogenetic mixed
models (Housworth et al., 2004) that are
widely used to estimate the heritability from
a phylogenetic tree. These methods have
the advantage of being able to incorporate
larger study populations and transmission
relationships ranging from close pairing to distant
epidemiological linkage. We used the recent
implementation by Leventhal and Bonhoeﬀer
(Leventhal and Bonhoeﬀer, 2016) in the R
language of statistical computing (R Core Team,
2013). The models that underlie this method
assume trait evolution according to Brownian
motion, i. e. that traits drift neutrally. Brownian
motion is characterized by the diﬀusion constant
which is related to the heritability. Because we
use the method on a tree, the branch lengths
of which correspond to genetic distances, we
make the implicit assumption that heritability
increases linearly with genetic distance. Previous
studies used Pagel’s λ to estimate heritabilities
(Alizon et al., 2010; Shirreﬀ et al., 2013). We
refrained from using Pagels λ in our main analysis
because it is not as appropriate as phylogenetic
mixed model for non-ultrametric trees (as our
phylogenetic tree) (Leventhal and Bonhoeﬀer,
2016). However, as a point of comparison with
estimates of Pagels λ in previous studies, we
report our estimates of this quantity in the
supplementary material.
We also applied phylogenetic mixed models
based on the Ornstein-Uhlenbeck process that
describe stabilizing trait selection around an
optimal trait value rather than neutral drift. In
addition to the diﬀusion constant, this model
has a parameter for the trait value around
which selection stabilizes the trait, θ, and
another parameter describing the strength of
selection, α. In macroevolutionary applications,
the parameter α is often translated into a
characteristic time t1/2= ln(2)/α needed for the
trait to evolve halfway back to its optimum
(Hansen, 1997). The heritability in POUMM is
9
Bertels et al. · doi:10.1093/molbev/mst MBE
related to all three parameters of the Ornstein-
Uhlenbeck process (Mitov and Stadler, 2016). We
used the implementation by Mitov and Stadler
(2017).
Testing for genetic associations with
per-parasite pathogenicity
Previous studies identified a valine instead
of an isoleucine at position 62 and 64 in
the protease (I62V and I64V), and a proline
instead of an alanine at position 272 in the
reverse transcriptase as amino acid substitutions
that could be associated with per-parasite
pathogenicity (Ng et al., 2014) (see the Result
section for more details). To test for associations of
per-parasite pathogenicity with the substitutions
I62V, I64V, and A272P, we regressed per-parasite
pathogenicty, but also the other two traits, set-
point viral load and CD4+ T cells decline, against
categorical variables indicating the presence of the
mutated amino acid at the respective position.
The mutated amino acids were defined as a valine
in position 62 and 64 of the protease, and a proline
in position 272 of the reverse transcriptase. In
these regressions, we also included cofactors such
as age, sex and risk group.
An association with per-parasite pathogenicity
was assessed in two ways. First, we regressed
the proxy for per-parasite pathogenicity defined
above — residuals from the age-adjusted tolerance
curves — against the presence of the substitute
amino acid. Second, we regressed the rate of
change in the CD4+ T cells against the square
of the logarithm to the base of 10 of the set-
point viral load, including the presence of the
mutated amino acid at the respective position as
an interaction term. We also included the sex and
age at infection as cofactors in the analysis:
∆CD4 = (α0+η62PROT.V +η64PROT.V +η272RT.P
+ηM+ca)(log10V )
2+ϵ (1)
Here, ∆CD4 denotes the rate of change in the
CD4+ T cell level per microliter blood per
day. The parameter α0 describes the relationship
between set-point viral load and CD4+ T cells
decline for females with age zero that are
infected with a virus that does not express
any of the mutant amino acids we consider.
The remaining parameters describe the oﬀset
that can be attributed to the various cofactors:
η62PROT.V , η64PROT.V , and η272RT.P describe the
potential change in the relationship between set-
point viral load and CD4+ T cell decline due
to each considered amino acid substitution, and
ηM quantifies the change due to being male.
ca is the oﬀset to α0 in an individual of age
a. This procedure follows the approach we have
adopted previously to test for the association of
host factors with disease tolerance (Regoes et al.,
2014).
Results
Heritability of set-point viral load confirmed
The heritability of the set-point viral load has
previously been estimated from data of the Swiss
HIV cohort study (Alizon et al., 2010) and from
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data of other cohorts (Hodcroft et al., 2014;
Hollingsworth et al., 2010; Mu¨ller et al., 2011).
The methods diﬀered across these studies.
To test the conclusion of these studies,
we applied donor-recipient regressions and the
phylogenetic mixed models to the set-point viral
loads from the 2014 individuals we included in
the present study. The donor-recipient regressions
were applied to 196 previously determined
transmission pairs (Kouyos et al., 2014), while
the phylogenetic methods were applied to a
phylogenetic tree that was constructed from pol
gene sequences (see Methods and Materials). Since
set-point viral loads were significantly associated
with sex, age at infection, and were higher in men
who have sex with men, we also estimated the
heritability of adjusted set-point viral loads as
defined in the Methods and Materials.
Across all the methods we use, the estimates
for heritability range from 8% to 29% (see
Table 1, Fig 3B and Figure S2B. These estimates
are all significantly larger than zero, except
for the adjusted set-point viral load using the
phylogenetic mixed-model that assumes neutral
evolution. These results add to the growing
consensus that set-point viral load is heritable.
Interestingly, assuming stabilizing selection on
the set-point viral load in our phylogenetic
analysis led to a significantly better fit to the
data than assuming neutral drift (Likelihood ratio
test: p=1.2×10−4 for unadjusted and p=8.8×
10−6 for adjusted set-point viral loads). Thus,
the estimates for the heritability of the set-point
viral load with the best statistical support are
26% and 29% without and with adjustment for
cofactors, respectively. Both of these estimates are
significantly diﬀerent from zero.
The optimal trait value θ of the Ornstein-
Uhlenbeck process is estimated to be 104.0 RNA
copies per milliliter plasma for the unadjusted
set-point viral load (95% CI: 101.6−104.3 RNA
copies per milliliter plasma), very close to the
mean of the set-point viral load in our study
population 104.2 RNA copies per milliliter plasma
(see Table 2). The parameter measuring the
strength of selection, α is high: 32.7 (95% CI: 0.03-
57.6) and 39.4 (95% CI: 6.1-68.1) for unadjusted
and adjusted set-point viral load, respectively
(see Table 2). These parameter estimates are
consistent with strong stabilizing selection around
the current mean trait value.
Evidence for the heritability of CD4+ T cell
decline
The set-point viral load is an important
determinant of CD4+ T cell decline, and it is
heritable. We therefore expect the CD4+ T cell
decline to be also heritable “by association”. So
far, however, there has been no evidence for the
heritability of the CD4+ T cell decline or HIV
virulence.
To assess the heritability of the CD4+ T cell
decline, we applied the same methods as for the
set-point viral load. Because the CD4+ T cell
decline was associated significantly only with the
11
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FIG. 3. Heritability estimates from donor-recipient regressions. For these regressions we plotted the trait values
for each partner (“partner 1” and “partner 2”) in the transmission pairs onto the x- and y-axis. Since we do not know
the direction of the transmission in the pairs, the assignment of the partners to either x- or y-axis is random. (See also
Figure S2.)
Table 1. Heritability estimates for set-point viral load (spVL), CD4+ T cell decline (∆CD4) and per-parasite pathogenicity
(ppp) based on the phylogenetic mixed models assuming Brownian motion-type trait evolution (PMM) or trait evolution
according to the Ornstein-Uhlenbeck process (POUMM). 95% confidence intervals are given in brackets.
PMM POUMM
∆CD4 (unadjusted) 25% (9%–40%) 17% (6%–29%)
∆CD4 (adjusted) 24% (7%–39%) 17% (5%–30%)
spVL (unadjusted) 12% (2%–28%) 26% (8%–43%)
spVL (adjusted) 8% (0%–26%) 29% (12%–46%)
ppp 22% (5%–39%) 17% (4%–29%)
age at infection we also conducted the analyses
with age-adjusted CD4+ T cell declines as defined
in the Methods and Materials.
The donor-recipient regression (Fig 3A) results
in a hertability estimate, which is not significantly
diﬀerent from zero for both unadjusted and age-
adjusted CD4+ T cell declines. This is likely
the result of the low number of individuals in
the transmission pairs (2×196), which limits
the statistical power of the donor-recipient
regressions.
Using the phylogenetic mixed models, however,
we can incorporate all 2014 individuals of
our study population, and obtain heritability
estimates significantly larger than zero. Assuming
neutral trait evolution (PMM) yields 25% and
24% for unadjusted and adjusted CD4+ T
cell declines, respectively. With trait evolution
according to the Ornstein-Uhlenbeck process we
get 17% irrespective of any adjustment (see
Table 1).
Again, assuming trait evolution according
to an Ornstein-Uhlenbeck process has more
12
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statistical support than Brownian motion trait
evolution (Likelihood ratio test: p=6.9×10−8 for
unadjusted and p=2.6×10−5 for adjusted CD4+
T cell declines). But, unlike for the set-point
viral load, the estimate of the optimal trait
value θ (-1.15 per day, 95% CI: -2.43 to -0.29
per day) is significantly below the mean of the
CD4+ T cell declines in our study population
(-0.20 per day), and the estimated strength
of selection α is an order of magnitude lower
than that for the set-point viral load (4.1 and
3.8 for unadjusted and adjusted CD4+ T cell
decline, respectively). See Table 2 for all selection
related parameter estimates for this trait. These
parameters characterize directional, rather than
stabilizing selection, consistent with a slow time
trend towards higher virulence.
Evidence for the heritability of the
per-parasite pathogenicity
Lastly, we investigated if there is any evidence for
the heritability of the per-parasite pathogenicity.
The per-parasite pathogenicity is the component
of virulence, which is determined by the pathogen
genotype and independent of the pathogen load.
Formally, we determine per-parasite pathogenicity
by calculating the residual of the regression of the
CD4+ T cell decline against the set-point viral
load adjusted for the age of the infected individual
(see Material and Methods and Fig 2).
A donor-recipient regression (Fig 3C) yields
an estimate, which is not significantly diﬀerent
from zero, again likely due to the low number
of transmission pairs. Using phylogenetic mixed
models, we estimate a statistically significant
heritability of 22% assuming Brownian motion-
type trait evolution, and 17% for trait evolution
according to the Ornstein-Uhlenbeck process (see
Table 1).
As for the set-point viral load and the CD4+
T cell decline, assuming trait evolution governed
by an Ornstein-Uhlenbeck process led to a
significantly better fit than evolution according to
Brownian motion (Likelihood ratio test: p=2.2×
10−6). The pattern of selection most consistent
with the evolution of per-parasite pathogenicity
is directional selection as for the CD4+ T cell
decline: the optimal trait value is estimated to be
significantly lower than the population mean, and
the strength of selection is weak (see Table 2).
This suggests that there is a slow time trend of
increasing per-parasite pathogenicity.
Testing for genetic associations with
per-parasite pathogenicity
It is known that HIV-1 subtype D has a higher
per-parasite pathogenicity than subtype A. These
intersubtype diﬀerence in disease progression have
been mapped to the pol gene and were associated
with replicative capacity (Ng et al., 2014). In
particular, a valine instead of an isoleucine at
position 62 and 64 in the protease (I62V and
I64V), and a proline instead of an alanine at
position 272 in the reverse transcriptase were
found to be associated with high replicative
capacity (Ng et al., 2014)
13
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Table 2. Estimates of the POUMM parameters related to selection for set-point viral load (spVL), CD4+ T cell decline
(∆CD4) and per-parasite pathogenicity (ppp) 95% confidence intervals are given in brackets.
α θ population mean
∆CD4 (unadjusted) 4.1 (0.5 – 10.8) -1.15 (-2.43 – -0.29) -0.20
∆CD4 (adjusted) 3.8 (0.4 – 10.5) -0.93 (-2.30 – -0.06) -0.04
spVL (unadjusted) 32.7 (0.03 – 57.6) 4.0 (1.6 – 4.3) 4.2
spVL (adjusted) 39.4 (6.1 – 68.1) -0.03 (-0.17 – 0.10) -0.04
ppp 3.9 (0.5 – 10.4) -0.89 (-2.17 – -0.09) 0.00
We tested if these amino acid polymorphisms
are associated with set-point viral load, CD4+
T cell decline, and per-parasite pathogenicity
within HIV-1 subtype B. Indeed isoleucine and
valine at positions 62 and 64 of the protease, and
alanine and proline at position 272 in the reverse
transcriptase were the most prevalent amino
acids in our study population. The set-point
viral load was not associated with any of these
polymorphisms. Before adjustment for multiple
comparisons, the association of proline at position
272 in the reverse transcriptase with CD4+
T cell decline and per-parasite pathogenicity
reach a significance level of p=0.014 and p=
0.020, respectively, which is not significant after
adjusting the p-values for three comparisons.
Discussion
In this study, we confirmed the heritability of the
set-point viral load. Further, we report one of the
first pieces of evidence for the heritability of the
CD4+ T cell decline, a surrogate of virulence. We
also found support for the hypothesis that the
pathogen-load-independent virulence component
is heritable. Lastly, the evolution of these three
traits is significantly better described by the
Ornstein-Uhlenbeck process than by Brownian
motion.
Our study confirms previous studies that
established the heritability of the set-point viral
load in HIV infection (as reviewed by Mu¨ller
et al. (2011) and Fraser et al. (2014)). In
particular, our estimates are consistent with those
from a donor-recipient regression in Hollingsworth
et al. (2010), and two recent studies applying
phylogenetic mixed models based on the Ornstein-
Uhlenbeck process by Mitov and Stadler (2016)
and Blanquart et al. (2017). Our analysis is
also consistent with the study by Hodcroft
et al. (2014) that reported a low heritability
of 5.7% of the set-point viral load adjusted for
covariates and assuming Brownian trait evolution.
If we adjust for covariates and assume Brownian
trait evolution, we obtain a heritability estimate
of 8% that is not significantly diﬀerent from
zero. Assuming trait evolution according to the
Ornstein-Uhlenbeck process, however, provides a
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significantly better fit to the adjusted set-point
viral load data and yields a heritability estimate
of 29%.
We find clear evidence for the heritability of the
CD4+ T cell decline. As the level of CD4+ T
cells is a defining characteristic of clinical AIDS,
the CD4+ T cell decline is a good surrogate of
virulence of HIV infection. Although the potential
heritability of the rate of decline of CD4+ T
cells has been investigated previously (Alizon
et al., 2010), it was found to be not significantly
diﬀerent from zero. We attribute this discrepancy
to the low sample size of the earlier study. In
contrast to the 2014 individuals in our study
population, Alizon et al. (2010) had enrolled
only 1100 and investigated the heritability only
in subpopulations consisting of a few hundered
individuals.
The recent study by Blanquart et al. (2017)
also reports heritability of the CD4+ T cell
decline. For the HIV-1 subtype B, they estimate a
heritability of 11% ranging from 0% to 19%. This
estimate is within the 95% confidence intervals of
our estimate, and our estimate of 17% is within
the 95% confidence intervals of their estimate.
Unlike our analysis, Blanquart et al. (2017) did
not find support for the Ornstein-Uhlenbeck over
the Brownian motion trait evolution model. Their
estimate of the strength of selection on the CD4+
T cell decline is 0.095 whereas we estimate 3.8.
This may be due to the lower sample size of
1170 individuals in the study by Blanquart et al.
(2017). It may also be the result of diﬀerences
in the inclusion criteria: Blanquart et al. (2017)
included individuals with five CD4+ T cell
measures between the time of their first positive
HIV test and the beginning of treatment, while
we require only three CD4+ T cells but in a more
stringent time window that excludes the first 90
days after the estimated time of infection and time
points, after the CD4+ T cell count fell below 100
cells per microliter blood. Diﬀerences in the tree
reconstruction algorithm, however, are unlikely
to explain the discrepancy. If we reconstruct
the phylogenetic tree with RaxML (Stamatakis,
2006b), which is closely related to ExaML (Kozlov
et al., 2015) that Blanquart et al. (2017) used,
we obtain very similar parameter estimates (see
Table S1). The heritability estimates based on the
FastTree and RaxML trees are most discrepant
for the adjusted set-point viral load when we use
POUMM (29% versus 34% or 38%), but, because
of the large confidence intervals, these estimates
are not statistically diﬀerent. With the RaxML
trees, we also find that Ornstein-Uhlenbeck trait
evolution has higher statistical support.
We also provide evidence for the heritability
of the per-parasite pathogenicity. This trait
describes the pathogenic potential of a viral
strain that is independent of the load the strain
attains in its host. We approximated this trait
as the deviation of the CD4+ T cell decline
observed in an individual from that predicted
on the basis of the observed set-point viral load
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and the age of the infected host (see Methods).
In addition to being determined by per-parasite
pathogenicity, this deviation could be aﬀected by
further host factors, other sources of biological
variation, and, of course, measurement noise,
and should therefore be considered only as a
surrogate for the per-parasite pathogenicity of a
strain. It is important to note, however, that the
uncertainties surrounding the quantification of the
per-parasite pathogenicity make it more diﬃcult
to establish the heritability of this trait. The fact
that we found evidence for heritability means that
the signal in our surrogate measure of the per-
parasite pathogenicity is not completely clouded
by factors, for which we could not account.
For all three traits we considered, the Ornstein-
Uhlenbeck trait evolution model has the best
statistical support. For the set-point viral load
the strength of selection is estimated to be high,
and the inferred optimal value of the trait is close
to the mean of the set-point viral load in our
study population. Thus, set-point viral load is
under significant stabilizing selection. The CD4+
T cell decline and the per-parasite pathogenicity,
on the other hand, are not under strong stabilizing
selection but directional selection — a scenario
that the Ornstein-Uhlenbeck trait evolution model
can capture with low selection strength α and an
optimal trait value θ significantly diﬀerent from
the population mean. The parameter estimates of
the Ornstein-Uhlenbeck model for these two traits
are consistent with a slow but significant increase
in HIV virulence over the past two decades
(Pantazis et al., 2014). It is well-recognized that
the Ornstein-Uhlenbeck trait evolution model
can accommodate these two distinct patterns of
selection. The diﬀerence in the nature of selection
between set-point viral load and the other two
traits is also the reason behind the bias in the
heritability estimates based on Brownian motion
trait evolution: the heritability of the set-point
viral load is underestimated, while those of the
other two traits are slightly overestimated. This
conclusion is in agreement with simulation studies
of this bias (Mitov and Stadler, 2017).
Intuitively, the heritability of the CD4+ T cell
decline should be the combination of set-point
viral load dependent and independent components
of this trait. The heritability estimates we
obtained conform surprisingly well with this
expectation. The estimate of the heritability of the
CD4+ T cell decline with the highest statistical
support is 17%. The adjusted set-point viral load
has a heritability of 29%. To approximate to
what extent the heritability of the set-point viral
load will trickle through to that of the CD4+ T
cell decline, we need to factor in the correlation
between these two traits. In our study population,
the fraction of the variation in the CD4+ T cell
decline explained by the set-point-viral load is
R2=0.057, in very close agreement with estimates
of this quantity in other study populations
(Rodriguez et al., 2006). Thus, approximately
29%×0.057=1.6% of the 17.4% of the heritability
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in the CD4+ T cell decline are due to the set-point
viral load. The remainder — about 16% — should
be independent of the set-point viral load. This
agrees well with our estimate of the heritability of
the per-parasite pathogenicity of 17%, especially
given the uncertainty in all of these estimates.
The heritability of the per-parasite
pathogenicity means that there are viral genes
that influence the CD4+ T cell decline in
ways that do not depend on the viral load.
Generally, one conceivable such mechanism could
be that viral genotypes with high per-parasite
pathogenicity elicit ineﬀective immune responses
that, rather than reducing viral load, accelerate
CD4+ T cell decline. In terms of specific viral
factors influencing per-parasite pathogenicity,
studies that compare the disease course across
HIV-1 subtypes are illuminating. In particular,
the coreceptor usage (Daar et al., 2007) and pol
replicative capacity (Barbour et al., 2004; Goetz
et al., 2010; Ng et al., 2014) have been found to
be associated with the rate of disease progression
independently of the set-point viral load. Ng et al.
(2014) identified three amino acid polymorphisms
that are associated with replicative capacity.
We tested if these polymorphisms are associated
with per-parasite pathogenicity, CD4+ T cell
decline and set-point viral load. While we could
not establish any clear-cut association after
adjusting for multiple comparisons, a proline
at position 272 of the reverse transcriptase was
the most promising candidate. The sample size
for this test was lower (n=1222) than the size
of our study population (n=2014) because the
sequence region containing position 272 in the
reverse transcriptase was not available in all
individuals. This polymorphisms should be tested
in the future for an association with CD4+ T cell
decline and per-parasite pathogenicity in a larger
study population.
Previously, Pagel’s λ was also employed to
estimate the heritability of the set-point viral load
from a phylogenetic tree of HIV pol sequences
(Alizon et al., 2010). Leventhal and Bonhoeﬀer
(Leventhal and Bonhoeﬀer, 2016), however, have
argued recently that Pagel’s λ implicitly assumes
the trees to be ultrametric. Thus, for non-
ultrametric phylogenetic trees, such as the one
we analyzed, this essential assumption of Pagel’s
λ is violated, and this method should therefore
not be used. We nevertheless provide heritability
estimates for comparison in Figure S1. With
Pagel’s λ the set-point viral load and the CD4+
T cell decline are also found to be significantly
heritable.
The heritability of traits from donor to recipient
is sometimes interpreted as the quantitative
measure of the extent to which the trait is “under
the control of the virus”. It has been pointed
out that the viral genome carries an imprint
of past environments, in particular the immune
responses experienced in former hosts (Bartha
et al., 2013, 2017; Carlson et al., 2014, 2016; van
Dorp et al., 2014). Thus, separating virus from
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host eﬀects is challenging. What is undisputed is
that the trait in the new host is in part encoded in
the viral genome. Information on associations with
viral genes is very valuable, especially for traits
that cannot be determined instantaneously, such
as the CD4+ T cell decline.
In summary, we presented a comprehensive
evolutionary analysis of the components of
HIV virulence. We established that viral
load dependent and independent virulence
components, as well as overall virulence
are heritable. This strongly suggests that
these virulence components are, at least in
part, encoded in the viral genome. Future
research will need to identify the specific genetic
polymorphisms associated with these virulence
components.
Supplementary Material
Supplementary table S1 and figures S1–S2 are
available at Molecular Biology and Evolution
online (http://www.mbe.oxfordjournals.org/).
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